Stemsation International Financials
STSN Stock | USD 0.01 0.0005 3.70% |
Stemsation |
Understanding current and past Stemsation International Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Stemsation International's financial statements are interrelated, with each one affecting the others. For example, an increase in Stemsation International's assets may result in an increase in income on the income statement.
Stemsation International Stock Summary
StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. StemSation International, Inc. is headquartered in Boca Raton, Florida. Sternsation International operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
ISIN | US85859E1029 |
Business Address | 7777 Glades Road, |
Sector | Healthcare |
Industry | Drug Manufacturers—Specialty & Generic |
Benchmark | Dow Jones Industrial |
Website | www.stemsation.global |
Phone | 561 245 7454 |
Currency | USD - US Dollar |
Stemsation International Key Financial Ratios
Stemsation International's financial ratios allow both analysts and investors to convert raw data from Stemsation International's financial statements into concise, actionable information that can be used to evaluate the performance of Stemsation International over time and compare it to other companies across industries.Stemsation Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Stemsation International's current stock value. Our valuation model uses many indicators to compare Stemsation International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stemsation International competition to find correlations between indicators driving Stemsation International's intrinsic value. More Info.Stemsation International is rated below average in current valuation category among its peers. It is rated fifth in shares outstanding category among its peers creating about 6.50 of Shares Outstanding per Current Valuation. Comparative valuation analysis is a catch-all model that can be used if you cannot value Stemsation International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Stemsation International's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Stemsation International Systematic Risk
Stemsation International's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Stemsation International volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Stemsation International correlated with the market. If Beta is less than 0 Stemsation International generally moves in the opposite direction as compared to the market. If Stemsation International Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Stemsation International is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Stemsation International is generally in the same direction as the market. If Beta > 1 Stemsation International moves generally in the same direction as, but more than the movement of the benchmark.
Stemsation International November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Stemsation International help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Stemsation International. We use our internally-developed statistical techniques to arrive at the intrinsic value of Stemsation International based on widely used predictive technical indicators. In general, we focus on analyzing Stemsation Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Stemsation International's daily price indicators and compare them against related drivers.
Downside Deviation | 19.5 | |||
Information Ratio | 0.0029 | |||
Maximum Drawdown | 77.75 | |||
Value At Risk | (32.40) | |||
Potential Upside | 27.37 |
Other Information on Investing in Stemsation Pink Sheet
Stemsation International financial ratios help investors to determine whether Stemsation Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stemsation with respect to the benefits of owning Stemsation International security.